eProtocol

HRECs

Human Research Ethics Committees (HRECs)

Role of HRECs

Our Human Research Ethics Committees (HRECs) are designed to review and where appropriate, approve and monitor human research projects. In doing so, each HREC also ensures that “all types of research involving or impacting on humans conform to the highest ethical standards of practice and academic integrity”.

Bellberry is certified to review clinical drug trials, social science and observational studies. We can also assist when there might be disagreement about clearly defining research versus quality assurance activities. The role of the HREC is to ensure participant interests are considered, especially where interventions are proposed that may incur risks, suffering or inconvenience. As occurs in clinical research, patients/participants should be provided with relevant information to enable them to determine if they wish to be involved in quality assurance activity.

Bellberry currently manages 12 Human Research Ethics Committees. We can hold up to 13 HREC meetings per month and can hold additional meetings when required. Please contact Bellberry before submitting your documents if you have specific time frames.

Bellberry holds meetings every Wednesday evening. Submission of study documentation must occur via eProtocol two weeks before a meeting.

Click here to access the Bellberry HREC Terms of Reference.


Our Chairs

The Bellberry HREC’s are chaired by:

  • Adjunct A/Professor Brian Stoffell, Flinders University and Principal, BFS Consulting
  • A/Professor Mark Slee, Flinders University and Senior Consultant Neurologist in the Southern Adelaide Local Health Network (SALHN)
  • Dr Michael James, Research Officer, Rheumatology Unit, Royal Adelaide Hospital
  • Dr Barry Chatterton, Associate Professor within the Discipline of Medicine at University of Adelaide (retired), Senior Director Nuclear Medicine Royal Adelaide Hospital and Physician in Nuclear Medicine in private practice (both retired)
  • Dr Jeff Karrasch, Consultant Physician, St. Vincents Hospital Northside and North West Private Hospitals, Brisbane
  • Professor Annette Braunack-Mayer, Head, School of Health and Society, University of Wollongong
  • Professor Ben Canny, Director, Medical Education, University of Adelaide & Adjunct Professor, Monash University
  • Ms June Challen, Senior Pharmacist – Investigational Drugs, The Queen Elizabeth Hospital, Central Adelaide Local Health Network
  • A/Professor Michael Ward, Discipline Leader: Pharmacy Education, Professorial Lead: Pharmacy and Biosciences, Clinical and Health Sciences, University of South Australia
  • A/Professor Mark Slee, Flinders University and Senior Consultant Neurologist in the Southern Adelaide Local Health Network (SALHN)